ABHY yields 5.19% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, ABHY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABHY + JNJ for your $10,000?
ABHY tracks an index that invests in US-listed high yield ETFs while applying a downside protection. The risk-managed fund employs a tactical strategy that toggles between high yield and US Treasury ETFs. This tactical switch is determined by a daily buy-sell signal. Full exposure is allocated to high yield ETFs when a buy signal is triggered, while 80% is allocated to US Treasurys when it triggers otherwise. Underlying ETFs must meet certain expense ratio and AUM requirements to be considered. In addition, both must have an investment process that excludes factors, hedges and long/short strategies. The underlying ETFs are weighted based on their respective expenses and AUM, whether its junk bonds or Treasurys. The index is rebalanced quarterly and reconstituted annually. DFHYs investors should anticipate frequent trading. Prior to Nov. 29, 2021, the fund was named TrimTabs Donoghue Forlines Tactical High Yield and tracked the TrimTabs Donoghue Forlines Tactical High Yield Index. Prior to Nov. 13, 2024 the fund name was Donoghue Forlines Tactical High Yield ETF and traded under the ticker DFHY.
Full ABHY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.